Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort study.
Journal of hepatology | 2003-01-01 | PMID 12480565
Akuta Norio, Tsubota Akihito, Suzuki Fumitaka and 8 more
